Cambria Investment Management, L.P. Eli Lilly & CO Transaction History

Cambria Investment Management, L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$106.92 - $132.43 $4.06 Million - $5.03 Million	-38,012 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $53,395 - $58,080	500 Added 1.33%	38,012 $4.25 Million
Q2 2019 Aug 12, 2019	BUY	$110.79 - $129.32 $20,828 - $24,312	188 Added 0.5%	37,512 $4.16 Million
Q1 2019 May 08, 2019	SELL	$111.31 - $131.02 $83,927 - $98,789	-754 Reduced 1.98%	37,324 $4.84 Million
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $797,321 - $893,240	-7,529 Reduced 16.51%	38,078 $4.41 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $353,142 - $441,366	-4,113 Reduced 8.27%	45,607 $4.89 Million
Q2 2018 Jul 30, 2018	SELL	$75.7 - $86.88 $604,161 - $693,389	-7,981 Reduced 13.83%	49,720 $4.36 Million
Q1 2018 May 11, 2018	SELL	$74.21 - $87.6 $942,466 - $1.11 Million	-12,700 Reduced 18.04%	57,701 $4.46 Million
Q4 2017 Feb 12, 2018	BUY	$81.94 - $87.89 $122,582 - $131,483	1,496 Added 2.17%	70,401 $5.95 Million
Q3 2017 Nov 15, 2017	BUY	$77.07 - $85.54 $3.42 Million - $3.8 Million	44,387 Added 181.04%	68,905 $5.89 Million
Q2 2017 Aug 14, 2017	BUY	N/A	24,518	24,518 $2.02 Million

4,029

739M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Cambria Investment Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Cambria Investment Management, L.P. with notifications on news.